BDBM209003 US9233167, a-6-mPEG3-O-Codeine

SMILES: COCCOCCOCCOCCOCCOCCO[C@H]1C=CC2C3Cc4ccc(OC)c5OC1[C@]2(CCN3C)c45

InChI Key: InChIKey=IKEAYGVEBHZCFT-LXMWPHLLSA-N

Data: 2 KI  1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 209003   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mu-type opioid receptor (Homo sapiens (Human))	BDBM209003 (US9233167, a-6-mPEG3-O-Codeine) Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1C=CC2C3Cc4ccc(OC)c5OC1[C@]2(CCN3C)c45 |r,c:21,TLB:32:40:23:38.36.37,27:26:23:38.36.37| Show InChI InChI=1S/C31H47NO9/c1-32-9-8-31-24-5-7-27(30(31)41-29-26(34-3)6-4-23(28(29)31)22-25(24)32)40-21-20-39-19-18-38-17-16-37-15-14-36-13-12-35-11-10-33-2/h4-7,24-25,27,30H,8-22H2,1-3H3/t24?,25?,27-,30?,31-/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.42E+4	-6.61	n/a	n/a	n/a	n/a	n/a	n/a	25
Nektar Therapeutics US Patent					Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...				US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM209003 (US9233167, a-6-mPEG3-O-Codeine) Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1C=CC2C3Cc4ccc(OC)c5OC1[C@]2(CCN3C)c45 |r,c:21,TLB:32:40:23:38.36.37,27:26:23:38.36.37| Show InChI InChI=1S/C31H47NO9/c1-32-9-8-31-24-5-7-27(30(31)41-29-26(34-3)6-4-23(28(29)31)22-25(24)32)40-21-20-39-19-18-38-17-16-37-15-14-36-13-12-35-11-10-33-2/h4-7,24-25,27,30H,8-22H2,1-3H3/t24?,25?,27-,30?,31-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	>1.60E+5	>-5.17	n/a	n/a	n/a	n/a	n/a	n/a	25
Nektar Therapeutics US Patent					Assay Description Briefly, serial dilutions of the test compounds were placed in a 96-well plate to which were added SPA beads, membrane and radioligand. The assay con...				US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM209003 (US9233167, a-6-mPEG3-O-Codeine) Show SMILES COCCOCCOCCOCCOCCOCCO[C@H]1C=CC2C3Cc4ccc(OC)c5OC1[C@]2(CCN3C)c45 |r,c:21,TLB:32:40:23:38.36.37,27:26:23:38.36.37| Show InChI InChI=1S/C31H47NO9/c1-32-9-8-31-24-5-7-27(30(31)41-29-26(34-3)6-4-23(28(29)31)22-25(24)32)40-21-20-39-19-18-38-17-16-37-15-14-36-13-12-35-11-10-33-2/h4-7,24-25,27,30H,8-22H2,1-3H3/t24?,25?,27-,30?,31-/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	9.74E+4	n/a	n/a	n/a	25
Nektar Therapeutics US Patent					Assay Description Briefly, suspensions of cells expressing either the mu, kappa or delta opioid receptors were prepared in buffer containing 0.5 mM isobutyl-methyl xan...				US Patent US9233167 (2016) BindingDB Entry DOI: 10.7270/Q25T3J97
					More data for this Ligand-Target Pair